EPS International is part of EPS Holdings, Inc., a Japanese CRO. EPS is a comprehensive provider of clinical research outsourced services. Since its establishment in 1991, the EPS Group has grown to over 6,700 staff providing quality R&D support to pharmaceutical, biotech, regenerative medicine, and medical device companies. EPS operates in Japan, China, South Korea, Singapore, Taiwan and other Asia-Pacific countries. Looking towards the future, we will strengthen our forward-looking spirit expressed as an “Ever Progressing System.” Detailed information can be found at: http://www.eps-holdings.co.jp/en/.